ABCC1 and ovarian cancer: Here we show that combined treatment of emodin and cDDP induced a higher level of oxidative stress which was related to a more potent killing of cDDP-resistant ovarian cancer cells both in vitro and in vivo and stronger suppression of MRP1 expression.